|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
DONG SUNG PHARM. CO.,LTD.
Main Activities: Pharmaceutical and Medicine Manufacturing
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name DONG SUNG PHARM. CO.,LTD. Headquarters 703-14, BANGHAK 1-DONG, DOBONG-GU, SEOUL; Seoul; Seoul; 132853 |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational Financial Auditors: SEOIL (2011) Incorporation Date: November 25, 1957 Total Employees: 292 Tel: 02-6911-3600 |
|
Company Description |
| Growth trend continues with high technological competence and market competitiveness of products concerning hair dyes Seven Eight. Non-operating income decreased with increased interest expenses while net loss was posted with rising raw material prices and growing sales and admin expenses due to write-off of bad checks. Financial stability degraded from the preceding year with borrowings steadily obtained though operating cash flow improved with reduced inventory. Growth trend will continue with | ||
|
||
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
FULL COMPANY PROFILE
|
|
2012 Y (non-cons) |
2012 H1 (non-cons) |
|
 | ||
| Audited | Audited | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
XXX |
XXX |
| ||
Current Assets |
XXX |
XXX |
| ||
Total Liabilities |
XXX |
XXX |
| ||
Shareholders Equity |
XXX |
XXX |
| ||
Current Liabilities |
XXX |
XXX |
| ||
| * All the accounts are in KRW. | ||
Income Statement
| ||
Total Operating Revenue |
XXX |
XXX |
| ||
Operational Profit (Loss) |
XXX |
XXX |
| ||
Net Profit (Loss) |
XXX |
XXX |
| ||
| * All the accounts are in KRW. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
XXX |
XXX |
| ||
Return on Equity (ROE) |
XXX |
XXX |
| ||
Return on Sales (ROS) |
XXX |
XXX |
| ||
Return on Capital |
XXX |
XXX |
| ||
Gross Profit Margin |
XXX |
XXX |
| Efficiency Ratios | ||
| ||
Current asset turnover |
XXX |
XXX |
| ||
Asset Turnover |
XXX |
XXX |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
XXX |
XXX |
| ||
EBITDA |
XXX |
XXX |
| ||
Bookvalue (BV) |
XXX |
XXX |
| Liquidity Ratios | ||
| ||
Current Ratio |
XXX |
XXX |
| ||
Quick ratio |
XXX |
XXX |
| ||
Doom's day ratio |
XXX |
XXX |
| ||
Cash Flow to Debt |
XXX |
XXX |
| Leverage Ratios | ||
| ||
Leverage ratio |
XXX |
XXX |
| ||
Interest Coverage Ratio |
XXX |
XXX |
| ||
Debt to equity |
XXX |
XXX |
| ||
Debt to total assets |
XXX |
XXX |
| ||
Long Term Debt to Capital |
XXX |
XXX |
| Market ratios | ||
| ||
Price/Book Ratio |
XXX |
XXX |
| Trend Ratios | ||
| ||
Revenue Trend |
XXX |
XXX |
| ||
Net Income Trend |
XXX |
XXX |
| ||
 |